Ricardo Komotar, M.D.

Miller School Offers Brain Cancer Vaccine to Recurrent Cases


A revolutionary brain cancer vaccine clinical trial once limited to patients with newly diagnosed glioblastoma multiforme is now offered to UHealth patients with a recurrent brain tumor. As in the original study, the patient’s own tumor cells are used to develop the vaccine that is designed to target the immune system, offering hope to those with the most common and aggressive form of brain tumor.

Sylvester Comprehensive Cancer Center.

Sylvester Recognized for Outstanding Cancer Care


The Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine was given a perfect score from the Quality Oncology Practice Initiative (QOPI) Certification Program of the American Society of Clinical Oncology (ASCO). This program awards a three-year certification for outpatient hematology-oncology practices that meet their highest standards for quality cancer care.